Navigation Links
Baxter Kidney Patient Education Program Celebrates Tenth Anniversary
Date:11/5/2007

rowing prevalence of CKD has led to an increased need for patient education. The National Kidney Foundation estimates that at least 20 million Americans have CKD and 20 million more are at risk. About 400,000 patients have been diagnosed with End-Stage Renal Disease (ESRD), which requires dialysis or a kidney transplant to stay alive, and the number is projected to rise to more than 660,000 by 2010.

This growth in kidney dialysis patients has created a need for not only reliable information, but for professionals who can translate medical information into simple, understandable terms. A CKD patient transitioning to ongoing dialysis treatment has to quickly learn complicated medical concepts and how to ask their doctor the right questions about their care options. A KPE provides a valuable indirect service to nephrologists and nurses by accelerating patient understanding and following up with patients as they weigh their treatment options and consider lifestyle implications.

"When we first meet a patient, we reinforce what the nephrologist has already told them about kidney disease and provide additional information," said Barbour. "Later, we call to see if they have any questions we can answer, so that when they go back to see their doctor, they can have a more informed conversation on what they need to do and why. We continue to follow-up until they begin their therapy, to address additional specific questions and concerns that they may have."

This support is especially important for chronic kidney diseases that have no cure and where ongoing life-sustaining treatment is needed. Numerous research studies on patient education have shown that patients who are actively involved in making and understanding decisions about their therapy have better health outcomes and better adherence to their treatment plan.(1) Other studies have shown that patients who are educated and knowledgeable about their condition and treatment options have fewer complications
'/>"/>

SOURCE Baxter International Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
2. Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology
3. Baxter Named to Dow Jones Sustainability Index for Ninth Consecutive Year
4. Baxter and Novation Sign Multi-Year Contract Extension Valued at Over $200 Million for Medication Delivery Products
5. Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio
6. Novare Announces First Ever Single Port Laparoscopic Kidney Removal (Nephrectomy) Using RealHand(TM) HD Instruments
7. Genzyme to Participate in FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease
8. Diplomat Specialty Pharmacy Health Services Division Achieves High Marks in Pilot Program for Chronic Kidney Disease Management
9. Aidas Rh-Apo2L Clinical Testing Shows Preliminary Efficacy in Helping to Treat Lung Cancer, Stomach Cancer, Lymphoma, Pancreatic Cancer & Kidney Cancer
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... overlooked factor in the medical application of nanoparticles. ... on both radiofrequency heating and magnetic resonance image ... including detailed analysis of the aggregate morphologies based ... produce significant reductions in both heating and MRI ... quantify and correlate these effects for clinical applications, ...
(Date:9/2/2014)... 2, 2014 Persistence Market Research ... in Pharmaceutical, Biopharma and Life Sciences: North ... the global membrane technology market for pharmaceutical, biopharma and life sciences ... is expected to grow at a CAGR of 9.1% ... of USD 10,886.0 million in 2019. Browse ...
(Date:9/2/2014)... Sept. 2, 2014 Orexigen Therapeutics, Inc. (Nasdaq: ... Patent and Trademark Office (PTO) has issued a patent ... for weight loss. NB32 is a fixed-dose combination of ... U.S. Patent No. 8,815,889 claims methods for treating insulin ... patent expires in 2024. If NB32 is approved for ...
(Date:9/2/2014)... Mount, NC (PRWEB) September 02, 2014 ... establishment of its 11th clinical research site: PMG Research ... assumed ownership and operation of the clinical research department ... further expanding PMG’s presence in eastern North Carolina. This ... patients. For the patients in Rocky Mount and the ...
Breaking Biology Technology:Accounting for biological aggregation in heating and imaging of magnetic nanoparticles 2Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 2Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 3Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 4Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 5Orexigen Expands NB32 Intellectual Property Portfolio With New U.S. Patent 2Orexigen Expands NB32 Intellectual Property Portfolio With New U.S. Patent 3Orexigen Expands NB32 Intellectual Property Portfolio With New U.S. Patent 4PMG Research Announces the Formation of its Eleventh Site 2PMG Research Announces the Formation of its Eleventh Site 3
... Wis . - Can a heart patient's own stem cells be ... School of Medicine and Public Health intends to find out ... Hospital and Clinics . , ,The school is among the first ... which will investigate whether a person's own stem cells can treat ...
... - Deltanoid Pharmaceuticals , a privately held pharmaceutical ... clinical study of 2MD, its lead osteoporosis compound. , ... can safely improve bone mineral density in postmenopausal women. ... bone that results in susceptibility to fractures, occurs frequently ...
... - In a recent report that probably went ... University Technology Managers released figures that show why ... Wisconsin is a hotbed for scientific research. The numbers ... professors working in labs; it's about creating jobs for ...
Cached Biology Technology:UW tests adult stem cell role in regenerative heart care 2Tapping hidden assets: Wisconsin researchers who can create jobs 2Tapping hidden assets: Wisconsin researchers who can create jobs 3Tapping hidden assets: Wisconsin researchers who can create jobs 4
(Date:9/2/2014)... Human Genetics (ASHG) and the National Human Genome ... of Health, have named Elizabeth P. Tuck, MA, ... in Columbus, Ohio, the first ASHG/NHGRI Genetics and ... The Genetics and Education Fellowship is intended to ... and network to prepare for a career in ...
(Date:9/2/2014)... -- A team of University of Maryland physicists ... other scientists say make possible new nanostructures and ... energy and quantum computing advances to new sensor ... of Nature Communications the Maryland scientists, ... for hybrid nanostructures that uses a connector, or ...
(Date:9/2/2014)... new study that could ultimately lead to many new ... Research Institute (TSRI) have adapted a chemical approach to ... that can treat a form of muscular dystrophy. , ... a disease-causing defect as a catalyst to synthesize a ... Disney.,"Because the treatment is synthesized only in diseased cells, ...
Breaking Biology News(10 mins):ASHG and NHGRI award first genetics and education fellowship 2New synthesis method may shape future of nanostructures, clean energy 2New synthesis method may shape future of nanostructures, clean energy 3Scripps Florida scientists make diseased cells synthesize their own drug 2
... More atomic hydrogen gas the ultimate fuel for stars ... astronomer Dr Robert Braun has found.,This is the first accurate ... Just after the Big Bang the Universe,s matter was ... came together and generated galaxies, stars and planets and ...
... Agricultural Research and Development, have evaluated the effect of ... in sheep flocks. This disease mainly causes abortions, although ... and weakness in newborn lambs. The control of this ... it spreads easily among the animals and causes significant ...
... be held in Copenhagen, Denmark, on 4-5 June, ... the GMES Global Monitoring for Environment and Security ... User testimonials of pre-operational services, prospects for increased ... assessments will form the core of the conference ...
Cached Biology News:There's more star-stuff out there but it's not dark matter 2The effect of treatment with antibiotics and vaccination against Q fever in sheep 2The effect of treatment with antibiotics and vaccination against Q fever in sheep 3
... is a simple, easy to use ... bacterial and yeast applications. The ... voltages and either one mm, two ... pressing the pulse button the electroporator ...
... CGH Genomic Labeling Systems are a high-performance ... genomic DNA samples for array-based Comparative Genomic ... direct labeling formats, the BioPrime Plus Array ... solution to your genomic labeling needs. ...
MOUSE ANTI GTP BINDING PROTEIN...
The Cellject Elecroporator is suitable for all cell types including embryo, mammalian, plant, yeast and bacterial. Its has highly user-freindly programing and can be used remotely, for example in a l...
Biology Products: